GoHealth to Announce Fourth Quarter 2024 Results on February 27, 2025
CHICAGO, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- GoHealth, Inc. ( GoHealth ) ( NASDAQ: GOCO ) , a leading health insurance marketplace and Medicare-focused digital health company, announced that the company will release its fourth quarter 2024 financial results on the morning of February 27, 2025.
Orrstown Financial Services, Inc. Announces Promotion of Adam Metz to Senior Executive Vice President and Chief Operating Officer
HARRISBURG, Pa., Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Orrstown Financial Services, Inc. ( NASDAQ: ORRF ) ( the "Company" ) today announced that Adam L. Metz has been promoted to Senior Executive Vice President and Chief Operating Officer of the Company and its subsidiary bank, Orrstown Bank ( the ...
Actelis Networks Appoints Leading Industry Expert Julie Kunstler as Board Member
New Independent Director Brings decades of strategic expertise in broadband access and cybersecurity to support Actelis Networks' growth New Independent Director Brings decades of strategic expertise in broadband access and cybersecurity to support Actelis Networks' growth ...
Credit Acceptance Announces Conditional Notice of Redemption for Outstanding Senior Notes Due 2026
Southfield, Michigan, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Credit Acceptance Corporation ( Nasdaq: CACC ) ( referred to as the "Company", "Credit Acceptance", "we", "our", or "us" ) announced today that it has delivered a conditional notice of redemption to the trustee for the Company's 6.625% ...
Credit Acceptance Announces Conditional Notice of Redemption for Outstanding Senior Notes Due 2026 - Credit Acceptance ( NASDAQ:CACC )
Southfield, Michigan, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Credit Acceptance Corporation CACC ( referred to as the "Company", "Credit Acceptance", "we", "our", or "us" ) announced today that it has delivered a conditional notice of redemption to the trustee for the Company's 6.625% senior notes ...
Allogene Therapeutics Announces Publication of Durable Response Data from Phase 1 ALPHA/ALPHA2 Trials of the Allogeneic CAR T Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma in the Journal of Clinical Oncology
SOUTH SAN FRANCISCO, Calif., Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Allogene Therapeutics, Inc. ( Nasdaq: ALLO ) , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T ( AlloCAR Tâ„¢ ) products for cancer and autoimmune disease, today announced the publication of data ...
Cenovus to hold fourth-quarter and full-year conference call and webcast on February 20
CALGARY, Alberta, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Cenovus Energy Inc. ( TSX:CVE ) ( NYSE:CVE ) will release its fourth-quarter and full-year 2024 results on Thursday, February 20, 2025. The news release will provide consolidated fourth-quarter operating and financial information.
Opinion | As Trump's trade war gathers steam, China and Europe must cooperate
By fostering innovation and open markets - particularly in the automotive sector - China and the EU can show how major powers can work together despite differences.
Steve Jobs Feared His Porsche 911 Would Display His Wealth And Cost Him A $20 Million Deal-So He Scrambled To Hide It From Ross Perot - Apple ( NASDAQ:AAPL )
Steve Jobs was known for his obsession with perfection in the products he created and the cars he drove. His love for the Porsche 911 was legendary, and for years, he swapped his black Porsche for a new one every six months for a very Jobs-like reason - to avoid having a license plate.
Cenovus to hold fourth-quarter and full-year conference call and webcast on February 20 - Cenovus Energy ( NYSE:CVE )
CALGARY, Alberta, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Cenovus Energy Inc. CVE CVE will release its fourth-quarter and full-year 2024 results on Thursday, February 20, 2025. The news release will provide consolidated fourth-quarter operating and financial information.








